STOCKTON, CALIFORNIA/March 7, 2013 / Newswire/ — Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for an exclusive license of United States Provisional Patent Application 61672291, titled “Method of Making and Using a Universal Screening Health Testing Device that is a Metabolic and Wellness Testing Cart for Metabolic Syndromes and Diabetes with Measurements of VCO2, VO2, and Calculates a Respiratory Quotient, and other ways to Monitor and Evaluate Disease Risk and Treatment” from Health Care Intellectual Properties, LLC to Viratech, Corp, to treat abnormal or impaired metabolism and utilization of fats, sugars, proteins, and minerals.
Health Care Intellectual Properties is the holding company for Dr. Buckman’s patents licensed to Viratech on an exclusive basis. This will also allow Viratech to sub-license this technology to other companies.
Based on decades of clinical experience, this is a technology to improve care and screening of diabetes, pre-diabetes, and metabolic syndrome, all of which is frequently undiagnosed in the United States and other countries.
In many disease states there is inadequate use and body processing of ingested foods. Improper metabolism can lead to further complication of metabolic imbalances. As more and more of the population suffer from diabetes and obesity, there are more and more cases of insulin resistance and inability of glucose to get inside the cell where it is needed.
Sugar in the blood stream at elevated levels causes abnormalities of metabolism, damage to many organs, prevents the cells to access glucose for energy. There is also a need for improved metabolism, and better use of fats and carbohydrates.
This is a technology to screen, treat, and more effectively monitor modes of therapies for problems of metabolism, including diabetes.
Diabetes alone costs over $150 billion a year in medical costs, in just the United States.
Dr. Buckman, Viratech’s CEO, states, “When I was presenting at an international conference in Seoul, Korea just 2 years ago, many attendees asked me about the diabetes and cancer epidemic in developing countries as well as the Western World.” He added, “There is great need for new technologies such as this patent to find and monitor therapy of metabolic disorders such as diabetes.”
Dr. Buckman has written a variety of books: Find and Stop Breast Cancer, Find and Stop Diabetes, Find and Stop Body Imbalances, The Wellness Index, and books on other health related topics.
Viratech has a platform that can help with new technologies for licensing, sublicensing, promotion, business development, and marketing. Using this model, the Company anticipates sublicensing of the technologies from this agreement to support its model of light touch, low overhead, and make a difference for metabolic health.
About Viratech Corp.
Viratech Corp. has created the first open source biotech research social network platform. The purpose of the platform is to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. This has been made possible by leveraging social collaboration in a way that allows new biotech ventures the ability to protect their intellectual property, then simultaneously allowing those same ventures the ability to promote and crowdsource their development.
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Dr. Kevin Buckman
Viratech Corp.
http://viratech.org
Email Contact: info@viratech.org
209-477-3030